News Contact Us

U.S. government to purchase 100M doses of Moderna’s mRNA-1273 vaccine

Author : Saipriya Iyer | Published Date : 2020-08-13 

U.S. President Donald Trump has recently announced that the government will purchase 100 million doses of the experimental COVID-19 vaccine developed by Moderna. The vaccine is currently at the advanced stage of development.

In a separate statement made by the biotechnology company, its mRNA-1273 vaccine is reportedly worth over $1.53 billion. The company is also planning to offer the federal government an option to purchase additional doses of over 400 million. The country has initially invested $955 million for the development of this vaccine, bringing its total investment to nearly $2.48 billion.

The mRNA-1273 vaccine has reached the late-stage, human trials. In this human trial phase, the company will examine the safety and efficacy of the vaccine in 30,000 subjects or volunteers. It anticipates obtaining the results as early as October 2020. In addition to Moderna, the U.S. government also has signed deals with other vaccine developers such as Johnson & Johnson, and Pfizer.

Trump has reportedly stated that the country has invested in the top 6 vaccine candidates for their effective development and rapid delivery to date. He further added that the military is set to accelerate the vaccine delivery once it is fully approved for use by the U.S. FDA.

Furthermore, the U.S. Department of HHS (Health & Human Services) had previously announced its plan to invest $1.95 billion in BioNTech and Pfizer to produce 100 million vaccine doses, with the option to obtain additional 500 million doses. HHS also announced that it would invest $1 billion in J&J for 100 million vaccine doses, with the option to gain an additional 200 million doses.

The vaccine agreements signed between several companies and the U.S. government are part of its efforts to accelerate the distribution, manufacturing, and development of vaccines against the coronavirus, under the ‘Operation Warp Speed’ program.

Stephane Bancel, CEO of Moderna, has stated that the company would price the vaccine ‘well-below value’ during the pandemic and price up at the market value once the virus is contained.

Source credit:


About Author

Saipriya Iyer

Saipriya Iyer

Saipriya Iyer presently works as a content developer for fractovia.org. Having dabbled with the domain of content creation for nearly half a decade, she now boasts of an enviable portfolio, holding substantial experience in penning down pieces related to technology, finance, and a wide spectrum of other industry verticals. A qualified computer engineering graduate from the University of Pune, Saipriya can often be found leveraging her knowledge of software technology and electronics in her write-ups. She can be contacted at- [email protected] | https://twitter.com/saipriya_i

Related News

Adobe plans new hiring spree as the company hits record revenues

Published Date: 2020-09-17         Author: Saipriya Iyer

As the COVID-19 pandemic continues to impact the global business landscape, software companies and tech firms seem to be faring much better than other enterprises owing to their compatibility with the work-from-home trend, which ensures employee safety and smooth working of the organization. With ot... Read More

UK housing industry at its four year high according to estate agents

Published Date: 2020-09-11         Author: Saipriya Iyer

Stamp duty cuts and an upsurge in the demand for homes having gardens during the pandemic, has reportedly fueled the housing industry to its highest in the past four years, as per the estate agents and surveyors. Over 44% members of RICS’ (Royal Institute of Chartered Surveyors) have regist... Read More

Sydney share-trading firm Superhero secures over $8 million in capital

Published Date: 2020-09-07         Author: Saipriya Iyer

Superhero, an emerging Sydney-based share trading startup, has reportedly made its entry into the market with over $8 million in capital secured from some of Australia’s largest tech firms. The $8 million investment round was led by the chief and founder of BNPL fintech firm, Zip, Larry Dia... Read More

© 2020 Fractovia. All Rights Reserved